- World Pharma News Home » Published News » Clinical Trials
(a free service delivered by FeedBurner)
Novo Nordisk has initiated its first phase 1 clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a 2 million dollar payment to Emisphere Technologies, Inc., whose
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Facet Biotech Corporation (Nasdaq: FACT) and Bristol-Myers Squibb Company (NYSE: BMY) announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized ant
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novo Nordisk has initiated its first phase 1 clinical trial with an oral insulin analogue (NN1952). This milestone releases a USD 2 million payment to Merrion Pharmaceuticals plc, whose GIPET® techno
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
H. Lundbeck A/S announced the initiation of a multi-centre, placebo-controlled, fixed-dose study of Lu AE58054 as add-on to donepezil in patients with moderate Alzheimer's disease. The clinical phas
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novartis announced new interim data from ongoing clinical trials demonstrating that a single 7.5µg dose of the company's influenza A(H1N1) 2009 unadjuvanted vaccine, half of the currently-approved U
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Abbott (NYSE: ABT) today announced three-year data from the first 30 patients in the first phase of the ABSORB clinical trial, demonstrating that its fully bioabsorbable drug eluting coronary stent s
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The investigators reported that REOLYSIN was well tolerated when administered intravenously in combination with paclitaxel and carboplatin. Of 19 evaluable patients with head and neck cancer, mostly
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Amgen (Nasdaq: AMGN) today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-lin
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique a
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline (GSK) announced results from a second clinical trial of its pandemic (H1N1) adjuvanted vaccine, which demonstrate that one dose of the vaccine can provide a strong immune response whi
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
